Skip to main content

Allergic Eye Disease: Pathophysiology, Clinical Manifestations and Treatment

  • Chapter
Cornea and External Eye Disease

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Aguilar AJ (2000) Comparative study of clinical efficacy and tolerance in seasonal allergic conjunctivitis management with 0.1% olopatadine hydrochloride versus 0.05% ketotifen fumarate. Acta Ophthalmol Scand Suppl 78:52–55

    Article  Google Scholar 

  2. Akpek EK, Dart JK, Watson S, Christen W, Dursun D, Yoo S, O’Brien TP, Schein OD, Gottsch JD (2004) A randomized trial of topical cyclosporin 0.05% in topical steroid-resistant atopic keratoconjunctivitis. Ophthalmology 111(3):476–482

    PubMed  Google Scholar 

  3. Allansmith MR, Korb DR, Greiner JV, Henriquez AS, Simon MA, Finnemore VM (1977) Giant papillary conjunctivitis in contact lens wearers. Am J Ophthalmol 83:697–708

    CAS  PubMed  Google Scholar 

  4. Artal M, Luna J, Discepola M (2000) A forced choice comfort study of olopatadine hydrochloride 0.1% versus ketotifen fumarate 0.05%. Acta Ophthalmol Scand 78:64–65

    Article  Google Scholar 

  5. Ashrafzadeh A, Raizman MB (2003) New modalities in the treatment of ocular allergy. Int Ophthalmol Clin 43(1):105–110

    PubMed  Google Scholar 

  6. Bawazeer AM, Hodge WG, Lorimer B (2000) Atopy and keratoconus: a multivariate analysis. Br J Ophthalmol 129:667–668

    Google Scholar 

  7. Bielory L (2000) Allergic and immunologic disorders of the eye, part II: ocular allergy. J Allergy Clin Immunol 106:1019–1032

    CAS  PubMed  Google Scholar 

  8. Bielory L (2002) Ocular allergy guidelines: a practical treatment algorithm. Drugs 62(11):1611–1634

    Article  CAS  PubMed  Google Scholar 

  9. Bielory L, Kempuraj D, Theoharides T (2002) Topical immunopharmacology of ocular allergies. Curr Opin Allergy Clin Immunol 2:435–445

    PubMed  Google Scholar 

  10. Bonini S, Bonini S (1998) Pathogenesis of allergic conjunctivitis. In: Denburg JA (ed) Allergy, allergic diseases: the new mechanisms and therapeutics. Humana Press, Totowa, NJ

    Google Scholar 

  11. Bonini S, Bonini S, Lambaste A, March S, Pasqualetti P, Zuccaro O, Rama P, Magrini L, Juhas T, Bucci MG (2000) Vernal keratoconjunctivitis revisited: a case series of 195 patients with long-term follow up. Ophthalmology 107:1157–1163

    CAS  PubMed  Google Scholar 

  12. Bonini S, Coassin M, Aronni S, Lambiase A (2004) Vernal keratoconjunctivitis. Eye 18:345–351

    Article  CAS  PubMed  Google Scholar 

  13. Butrus S, Greiner JV, Discepola M, Finegold I (2000) Comparison of the clinical efficacy and comfort of olopatadine hydrochloride 0.1% ophthalmic solution and nedocromil sodium 2% ophthalmic solution in the human conjunctival allergen challenge model. Clin Ther 22:1462–1472

    Article  CAS  PubMed  Google Scholar 

  14. Cook EB, Stahl JL, Barney NP, Graziano FM (2000) Olopatadine inhibits TNFalpha release from human conjunctival mast cell. Ann Allergy Asthma Immunol 84:504–508

    CAS  PubMed  Google Scholar 

  15. Donshik PC, Pearlman D, Pinnas J, Raizman MB, Tauber J, Tinkelman D, Walters TR (2000) Efficacy and safety of ketorolac tromethamine 0.5% and levocabastine 0.05%: a multicentre comparison in patients with seasonal allergic conjunctivitis. Adv Ther 17(2):94–102

    CAS  PubMed  Google Scholar 

  16. Easty DL, Entwistle C, Fund A, Witcher J (1975) Herpes simplex keratitis and keratoconus in the atopic patient: a clinical and immunological study. Transcripts Ophthalmol Soc UK 95:267–276

    CAS  Google Scholar 

  17. Fahy GT, Easty DL, Collum LM, Benedict-Smith A, Hillery M, Parsons DG (1992) Randomized double-masked trial of lodoxamide and sodium cromoglycate in allergic eye disease. A multicentre study. Eur J Ophthalmol 2(3):144–149

    CAS  PubMed  Google Scholar 

  18. Foster CS, Calonge MD (1990) Atopic keratoconjunctivitis. Ophthalmology 97:992–1000

    CAS  PubMed  Google Scholar 

  19. Fukagawa K, Nakajima T, Saito H, Tsubota K, Shimmura S, Natori M, Hirai K (2000) IL-4 induces eotaxin production in corneal keratocytes but not in epithelial cells. Int Archiv Allergy Immunol 121:144–150

    CAS  Google Scholar 

  20. Heinz C, Fanihagh F, Steuhl KP (2003) Squamous cell carcinoma of the conjunctiva in patients with atopic eczema. Cornea 22:135–137

    Article  PubMed  Google Scholar 

  21. Hingorani M, Moodaley L, Calder VL, Buckley RJ, Lightman S (1998) A randomized, placebo-controlled trial of topical cyclosporin A in steroid-dependent atopic keratoconjunctivitis. Ophthalmology 105(9):1715–1720

    Article  CAS  PubMed  Google Scholar 

  22. Hogan MJ (1953) Atopic keratoconjunctivitis. Am J Ophthalmol 36:937–947

    CAS  PubMed  Google Scholar 

  23. John T (2000) Contact lens-induced allergic reactions. In: Abelson MB (ed) Allergic diseases of the eye. WB Saunders, Philadelphia

    Google Scholar 

  24. Kallen C, Reinhard T, Schilgen G, Cartsburg O, Bocking A, Auw-Hadrich C, Sundmacher R (2003) Atopic keratoconjunctivitis: probably a risk factor for the development of conjunctival carcinoma. Ophthalmologie 100:808–814

    CAS  Google Scholar 

  25. Keane-Myers AM, Miyazaki D, Liu G, Dekaris I, Ono SJ, Dana MR (1999) Prevention of allergic eye disease by treatment with IL-1 receptor antagonist. Invest Ophthalmol Vis Sci 40(12):3041–3046

    CAS  PubMed  Google Scholar 

  26. Korb DR, Allansmith MR, Greiner JV, Henriquez AS, Herman JP, Richmond PP, Finnemore VM (1981) Biomicroscopy of papillae associated with hard contact lens wearing. Ophthalmology 88: 1132–1136

    CAS  PubMed  Google Scholar 

  27. Korb DR, Allansmith MR, Greiner JV, Henriquez AS, Richmond PP, Finnemore VM (1980) Prevalence of conjunctival changes in wearers of hard contact lenses. Am J Ophthalmol 90:336–341

    CAS  PubMed  Google Scholar 

  28. Larkin DFP (1999) Immunological, neoplastic and degenerative diseases of the conjunctiva. In: Easty D, Sparrow J (eds) The Oxford textbook of ophthalmology. Oxford University Press, Oxford

    Google Scholar 

  29. Leonardi A, Busato F, Fregona I, Plebani M, Secchi AG (2000) Anti-inflammatory and antiallergic effects of ketorolac tromethamine in the conjunctival provocation model. Br J Ophthalmol 84(11): 1228–1132

    Article  CAS  PubMed  Google Scholar 

  30. Leonardi A, Secchi AG (2003) Vernal keratoconjunctivitis. Int Ophthalmol Clin 43:41–58

    PubMed  Google Scholar 

  31. McGill J (2000) Conjunctival cytokines in ocular allergy. Clin Exp Allergy 30:1355–1357

    Article  CAS  PubMed  Google Scholar 

  32. McGill JI, Holgate ST, Church MK, Anderson DF, Bacon A (1998) Allergic disease mechanisms. Br J Ophthalmol 82:1203–1214

    CAS  PubMed  Google Scholar 

  33. Messmer EM, May CA, Stefani FH, Welge-Luessen U, Kampik A (2002) Toxic eosinophil granule protein deposition in corneal ulceration and scars associated with atopic keratoconjunctivitis. Am J Ophthalmol 134:816–821

    Article  CAS  PubMed  Google Scholar 

  34. Metz DM, Bonini S, Lightman S (1993) mRNA expression for interleukin-2 interleukin-5 in vernal keratoconjunctivitis. Invest Ophthalmol Vis Sci 34:772

    Google Scholar 

  35. Metz DP, Bacon AS, Holgate ST, Lightman S (1996) Phenotypic characterization of T-cells infiltrating the conjunctiva in chronic allergic eye disease. J Allergy Clin Immunol 98:686–696

    Article  CAS  PubMed  Google Scholar 

  36. Miyazaki D, Liu G, Clark L, Ono SJ (2000) Prevention of acute allergic conjunctivitis and late phase inflammation with immunostimulatory DNA sequences. Invest Ophthalmol Vis Sci 41(12):3850–3855

    CAS  PubMed  Google Scholar 

  37. Miyazaki D, Nakamura T, Komatsu N, Nawata N, Ikeda Y, Inoue Y, Higashi H, Ono SJ (2004) Roles of chemokines in ocular allergy and possible therapeutic strategies. Cornea 23(Suppl 1):S48–54

    PubMed  Google Scholar 

  38. Miyazaki D, Nakamura T, Toda M, Cheung-Chau KW, Richardson R, Ono SJ (2005) Macrophage inflammatory protein-1alpha as a costimulatory signal for mast cell mediated immediate hypersensitivity reactions. J Clin Invest 115:434–442

    Article  CAS  PubMed  Google Scholar 

  39. Montan PG, Ekstrom K, Hedlin G, van Hage-Hamsten M, Hjern A, Herrmann B (1999) Vernal keratoconjunctivitis in a Stockholm ophthalmic centre: epidemiological, functional and immunological investigations. Acta Ophthalmol Scand 77:559–563

    CAS  PubMed  Google Scholar 

  40. Nishimura A, Campbell-Meltzer RS, Chute K, Orrell J, Ono SJ (2001) Genetics of allergic disease: evidence for organ-specific susceptibility genes. Int Archiv Allergy Immunol 124:197–200

    CAS  Google Scholar 

  41. Ono SJ, Abelson MB (2005) Allergic conjunctivitis: update on pathophysiology and prospects for future treatment. J Allergy Clin Immunol 115: 118–122

    Article  CAS  PubMed  Google Scholar 

  42. Raizman MB, Rothman JS, Maroun F, Rand WM (2000) Effect of rubbing on signs and symptoms of allergic conjunctivitis in cat-sensitive individuals. Ophthalmology 107(12):2158–2161

    Article  CAS  PubMed  Google Scholar 

  43. Santos CI, Huang AK, Abelson MB, Foster CS, Friedlaender M, McCulley JP (1994) Efficacy of lodoxamide 0.1% ophthalmic solution in resolving corneal epitheliopathy associated with vernal keratoconjunctivitis. Am J Ophthalmol 117(4): 488–497

    CAS  PubMed  Google Scholar 

  44. Sharif NA, Xu SX, Miller ST, Gamache DA, Yanni JM (1996) Characterization of the ocular antiallergic and antihistaminic effects of olopatadine (AL-4943A), a novel drug for treating ocular allergic diseases. J Pharmacol Exp Ther 278(3): 1252–1261

    CAS  PubMed  Google Scholar 

  45. Sitenga GL, Ing EB, Van Dellen RG, Younge BR, Leavitt JA (1996) Asthma caused by topical application of ketorolac. Ophthalmology 103(6):890–892

    CAS  PubMed  Google Scholar 

  46. Solomon A, Pe’er J, Levi-Schaffer F (2001) Advances in ocular allergy: basic mechanisms, clinical patterns and new therapies. Curr Opin Allergy Clin Immunol 1:477–482

    CAS  PubMed  Google Scholar 

  47. Solomon A, Puxeddu I, Levi-Schaffer F (2003) Fibrosis in ocular allergic inflammation: recent concepts in pathogenesis of ocular allergy. Curr Opin Allergy Clin Immunol 3:389–393

    PubMed  Google Scholar 

  48. Stahl JL, Barney NP (2004) Ocular allergic disease. Curr Opin Allergy Clin Immunol 4:455–459

    PubMed  Google Scholar 

  49. Tabbara KF (2003) Immunopathogenesis of chronic allergic conjunctivitis. Int Ophthalmol Clin 43(1):1–7

    PubMed  Google Scholar 

  50. Takano Y, Fukagawa K, Dora M, Santo-Kato N, Tsubota K, Fujishima H (2004) Inflammatory cells in brush cytology samples correlate with the severity of corneal lesions in atopic keratoconjunctivitis. Br J Ophthalmol 88:1504–1505

    Article  CAS  PubMed  Google Scholar 

  51. Trocme SD, Karan KS (2002) Spectrum of ocular allergy. Curr Opin Allergy Clin Immunol 2:423–427

    PubMed  Google Scholar 

  52. Tuft SJ, Dart JK, Kemeny M (1989) Limbal vernal keratoconjunctivitis: clinical characteristics and IgE expression compared with palpebral vernal. Eye 3:420–427

    PubMed  Google Scholar 

  53. Tuft SJ, Kemeny DM, Dart JK, Buckley RJ (1991) Clinical features of atopic keratoconjunctivitis. Ophthalmology 98(2):150–158

    CAS  PubMed  Google Scholar 

  54. Tuft SJ, Ramakrishnan M, Seal DV, Kemeny DM, Buckley RJ (1992) Role of Staphylococcus aureus in chronic allergic conjunctivitis. Ophthalmology 99:180–184

    CAS  PubMed  Google Scholar 

  55. Wakai K, Okamoto K, Tamakoshi A, Lin Y, Nakayama T, Ohno Y (2001) Seasonal allergic rhinoconjunctivitis and fatty acid intake: a cross-sectional study in Japan. Ann Epidemiol 11(1):59–64

    Article  CAS  PubMed  Google Scholar 

  56. Yokoi K, Yokoi N, Kinoshita S (1998) Impairment of ocular surface epithelium barrier function in patients with atopic dermatitis. Br J Ophthalmol 82:797–800

    CAS  PubMed  Google Scholar 

  57. Yoneda K, Okamoto H, Wada Y, Morita K, Takahashi M, Ogura Y, Imamura S (1995) Atopic retinal detachment: report of 4 cases and a review of the literature. Br J Dermatol 133(4):586–591

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2006 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Manzouri, B., Flynn, T., Ono, S.J. (2006). Allergic Eye Disease: Pathophysiology, Clinical Manifestations and Treatment. In: Reinhard, T., Larkin, D. (eds) Cornea and External Eye Disease. Essentials in Ophthalmology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/3-540-31226-9_14

Download citation

  • DOI: https://doi.org/10.1007/3-540-31226-9_14

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-22600-0

  • Online ISBN: 978-3-540-31226-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics